Clinical trial
Abiraterone-Rechallenge Study for CRPC Patients
NCT02656615
Study timeline
Study start (unknown)2016-01-01Date precision: month
Registry last updated2017-03-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
abiraterone acetateDRUG · verified · RxNorm: abiraterone acetate
Sponsors & collaborators
Aurelius Omlinlead sponsor
Cantonal Hospital of St. Gallencollaborator
University Hospital, Basel, Switzerlandcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02656615 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.